Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.26.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.122NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.431NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.6 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.343NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.409NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.310NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.362.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.162NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Y.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.353NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.407NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.182NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.218NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.12.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.22 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.123 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XRNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.350.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.154NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.137NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used